WHD-wrapup-header

World Hemophilia Day 2024 inspires thousands

The theme of World Hemophilia Day this year as “Equitable access for all: recognizing all bleeding disorders”, and the world embraced that theme with passion on April 17, 2024. Celebrations were held around the world, and buildings and monuments were lit up in red. The internet was buzzing with excitement as this important day for the global bleeding disorders community was celebrated once again.

Also available in: Français Español

It was uplifting to see how the enthusiasm of World Hemophilia Day percolated around the world in person and online. Over 150 monuments took part in the “Light it up Red” campaign, and countless gatherings were held around the world. Our story site—where anyone can share a story or a video about their experience with hemophilia—saw entries being uploaded all day long. Our social media posts on Facebook, Twitter, LinkedIn and Instagram were viewed over 43,000 times—nearly double our numbers from last year.

While it’s hard to single out stories from the many submissions we received on the World Hemophilia Day story site, here are three that we would like to share with you. We’ve taken out excerpts from the stories—if you want to read the full text, please click on the link.

 

Maryam Waleed Mahdi
Mother of a son with severe hemophilia A

“Navigating life with a child with hemophilia is an ongoing learning experience, but being part of a supportive community has made all the difference. We’ve learned to celebrate small victories, cherish resilient smiles, and find strength in unity. As we embrace the advancements in medical care and share our collective wisdom, we continue to move forward with courage and optimism.

To all the mothers out there facing the challenges of hemophilia, know that you are not alone. Your strength is commendable, and I am proud to stand beside you. Together, we celebrate our children’s resilience and the hope that comes with each new day, proving that life can be lived with courage and joy even in the face of hemophilia.”

To read Maryam Waleed Mahdi’s full story, please click here.

Eliza VanZweden
Person with Glanzmann’s thrombasthenia

“My name is Eliza VanZweden, and I am writing to share my journey as a woman living with Glanzmann’s Thrombasthenia. GT is a rare bleeding disorder caused by a platelet defect in which platelets do not aggregate to stop bleeding.

Although I still struggle with knowing when to get treatment for severe bleeds and don’t have access to prophylaxis treatment, preventative care has still been key in managing my bleeding disorder. This involves minimizing my risks in every activity or environment and being prepared for every situation.

The bleeding disorders community I have come to know through the WFH and the National Bleeding Disorders Foundation (NBDF) in the United States has proved to be an invaluable support and resource. I have met others who have the same bleeding disorder as I have and am inspired to be an advocate for this community <3.”

To read Eliza VanZweden’s full story, please click here.

Phyo Khant Kyaw
Person with hemophilia B

“In 1998, I was faced with the harsh reality of my condition when a simple injury to my gum led to a diagnosis that changed my life forever. At that time, diagnosing factor deficiency in Myanmar was a challenge, and I had been on a journey over thousand blood transfusions.

One of the most harrowing moments of my journey was experiencing an intracranial hemorrhage during my childhood. I was engulfed by fear, unable to speak, and unable to see the light. However, care and treatment provided by Professor Aye Aye Khaing, I got recovery within two weeks.

I am immensely grateful to the World Federation of Hemophilia (WFH), for saving my life and the lives of countless others affected by this condition. Through their initiatives and advocacy, individuals like myself have been given a chance at life, hope, and a brighter future.”

To read Phyo Khant Kyaw’s full story, please click here.


On behalf of the WFH and everyone in the bleeding disorders community, thank you for your support on World Hemophilia Day.

To learn more about this important event for the bleeding disorders community, please click here.

The WFH would like to thank our 2024 World Hemophilia Day sponsors for their continued support: Bayer, BioMarin Pharmaceutical Inc., Biotest, CSL Behring, F. Hoffman-La Roche Ltd., GC Pharma, Grifols, Kedrion, LFB S.A, Novo Nordisk, Octapharma, Pfizer, Sanofi, Sobi, Spark Therapeutics, and Takeda.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.